Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Update to Johnson & Johnson PFA platform gains FDA approval
The Varipulse PFA platform originally gained FDA approval in 2024. According to Johnson & Johnson MedTech, this update was put in place to help the technology provide better patient outcomes going forward.
AI-enhanced echocardiography improves early detection of cardiac amyloidosis
The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.
AI-enabled coronary plaque evaluations included in new RBM guidelines
The use of advanced AI software to assess CCTA images continues to gain more momentum.
ASE shares new recommendations for evaluating LV diastolic function, HFpEF
The new guidelines detail the use of echocardiography to evaluate patients for a variety of conditions.
Cardiology still No. 2 in FDA-cleared clinical AI algorithms, trailing only radiology
Cardiology continues to be one of the most influential healthcare specialties when it comes to utilizing artificial intelligence.

GE HealthCare Optison ultrasound enhancing agent

Cardiac ultrasound contrast completely safe, despite reports to the contrary

There had been a recent uptick in adverse reactions to contrast agents used in transthoracic or stress echocardiography exams, the findings suggest.

Imaging for chest pain: CT- and ICA-first strategies linked to similar long-term health status

These findings present additional evidence that invasive imaging tests are not necessarily more effective when it comes to evaluating patients for chest pain.

Unlike other UEA options, GE HealthCare's Optison does not contain polyethylene glycol. The FDA approved its use for adult patients back in 1997.

GE HealthCare debuts new wide-bore MRI scanner built with cardiology, oncology in mind

The new 1.5T MRI scanner includes a wide bore and key AI features designed to boost the patient experience.

ASNC, ACC ask US government not to tariff radiopharmaceuticals

The two groups stressed that tariffs would likely impact patient care.

Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Cardiologists are first in world to use new cooling device to terminate AFib during surgery

Patients often develop AFib during cardiac surgery, leading to longer hospital stays, additional healthcare costs and a higher risk of mortality. Cooling the oblique sinus of the patient's heart as soon as AFib starts to develop may represent a new way to stop the problem in its tracks.

Dan Budoff explains use of CCTA to track coronary disease plaque progression

CCTA shows colchicine's impact on atherosclerosis progression

Matthew Budoff, MD, detailed new data highlighting CCTA's value when it comes to tracking the progression of coronary atherosclerosis.

Cardiac Imaging

Update to Johnson & Johnson PFA platform gains FDA approval

AI-enhanced echocardiography improves early detection of cardiac amyloidosis

AI-enabled coronary plaque evaluations included in new RBM guidelines

ASE shares new recommendations for evaluating LV diastolic function, HFpEF

Cardiology still No. 2 in FDA-cleared clinical AI algorithms, trailing only radiology